Search
for
Sort by
Research 901–930 of 1000+
- Quercetin rescues dihydrotestosterone-treated human dermal papilla cells via SHP2/AKT signaling to suppress autophagy and apoptosis
- A subpopulation of itch‐sensing neurons marked by Ret and somatostatin expression
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Effects of mitotane treatment on human steroid metabolism: implications for patient management
- Anticancer effects of metformin on neuroendocrine tumor cells in vitro
- Prophylaxis and Management of Skin Toxicities
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study
- Drug-Induced Hair Changes
- Expression of CD117 and platelet-derived growth factor receptor α in patients with alopecia areata
- Successful Remission of Alopecia Areata and Seborrheic Dermatitis in a 21-Year-Old Male via Functional Nutrition and Advanced Diagnostics: A Case Report.
- 50285 Oxytocin receptor is present in keratinocytes near touch and pain sensory neurons
- Solitary, subcutaneous, fixed, firm, and fast-growing nodule
- Abstract ED05-04: Presurgical models to effectively screen preventive agents
- A Retrospective Evaluation of the Laboratory Findings of Dermatology Patients Whose Biotin Levels Were Checked
- Clinical Value Analysis of Pemetrexed Combined with Cisplatin in the Treatment of Non-Small Cell Lung Cancer
- The Case Files
- 51826 PRO-C22 - A Novel Serological Biomarker of Tissue Damage is Associated with Disease Severity, Disease Activity, and Systemic Inflammation in Patients with Hidradenitis Suppurativa
- Pemphigus Vulgaris IgG and Methylprednisolone Exhibit Reciprocal Effects on Keratinocytes
- Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis
- Retinoids and hair growth
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Trastuzumab Induced Chemobrain, Atorvastatin Rescued Chemobrain with Enhanced Anticancer Effect and without Hair Loss-Side Effect
- Emerging Strategies in Smart Nano-PROTAC for Stimuli-Responsive Protein Degradation and Precision Cancer Therapy
- Patient-reported outcome improvements following scalp hair regrowth among patients with Alopecia Areata: analysis of the ALLEGRO-2b/3 trial
- Transient Ca2+ entry by plasmalogen-mediated activation of receptor potential cation channel promotes AMPK activity
- Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment
- Population exposure–response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areata
- Unmasking Melasma: Confronting the Treatment Challenges